Latest Articles
AstraZeneca’s New Study on Endometrial Cancer Treatment: Key Insights for Investors - TipRanks
AstraZeneca’s New Study on Endometrial Cancer Treatment: Key Insights for Investors TipRanks
Published: Aug. 1, 2025, 4:33 p.m.
CD276xCD3 bispecific antibody shows preclinical promise for the treatment of endometrial cancer - BioWorld MedTech
CD276xCD3 bispecific antibody shows preclinical promise for the treatment of endometrial cancer BioWorld MedTech
Published: Aug. 1, 2025, 1 p.m.
Advancements and Breakthroughs in Endometrial Cancer Screening: A Current Overview - BIOENGINEER.ORG
Advancements and Breakthroughs in Endometrial Cancer Screening: A Current Overview BIOENGINEER.ORG
Published: July 31, 2025, 7:30 p.m.
Optimizing Therapy for MMR-Proficient Endometrial Cancer - OncLive
Optimizing Therapy for MMR-Proficient Endometrial Cancer OncLive
Published: July 31, 2025, 2:27 p.m.
Endometrial Cancer: Future Directions and Unmet Needs - OncLive
Endometrial Cancer: Future Directions and Unmet Needs OncLive
Published: July 31, 2025, 2:03 p.m.
Johor Specialist Hospital pioneers robotic sentinel node biopsy for endometrial cancer in the Southern region - Malaysiakini
Johor Specialist Hospital pioneers robotic sentinel node biopsy for endometrial cancer in the Southern region Malaysiakini
Published: July 31, 2025, 2:33 a.m.
First Early Endometrial Cancer Detection Test Launched By Gnosis - Inside Precision Medicine
First Early Endometrial Cancer Detection Test Launched By Gnosis Inside Precision Medicine
Published: July 30, 2025, 6:06 p.m.
First Early Endometrial Cancer Detection Test Launched by Gnosis - Inside Precision Medicine
First Early Endometrial Cancer Detection Test Launched by Gnosis Inside Precision Medicine
Published: July 30, 2025, 6:06 p.m.
Gnosis Launches EdenDx, the First Non-Invasive Liquid-Based Cytology U.S. Test for Early Endometrial Cancer Detection - PR Newswire
Gnosis Launches EdenDx, the First Non-Invasive Liquid-Based Cytology U.S. Test for Early Endometrial Cancer Detection PR Newswire
Published: July 30, 2025, 3:04 p.m.
Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights - Cureus
Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights Cureus
Published: July 30, 2025, 7:21 a.m.
Link copied to clipboard!